ArticleBreast cancer research : BCR2016

p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.

Emily Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.